EDEN PRAIRIE,
Minn., Aug. 11, 2021
/PRNewswire/ -- NeuroOne Medical Technologies Corporation
(NASDAQ: NMTC) (NeuroOne or the Company), a medical technology
company focused on improving surgical care options and outcomes for
patients suffering from neurological disorders, announces
today
it will host a conference call to discuss financial results
for its third quarter ended June 30,
2021, on August 13, 2021, at
9:00 AM ET.
Conference Call Information
Dial-in: (346) 248-7799
Meeting ID:
95665935395
Passcode:
902419
Webcast:
https://audience.mysequire.com/webinar-view?webinar_id=ebb66f45-34a2-4d94-b4b9-f830d498fc2f
About NeuroOne
NeuroOne Medical Technologies Corporation is a
developmental stage company committed to providing minimally
invasive and hi-definition solutions for EEG recording, brain
stimulation and ablation solutions for patients suffering from
epilepsy, Parkinson's disease, dystonia, essential tremors, chronic
pain due to failed back surgeries and other related neurological
disorders that may improve patient outcomes and reduce procedural
costs. For more information,
visit https://www.n1mtc.com.
The Company previously announced it had successfully met
the first performance milestone in the distribution and development
agreement signed with Zimmer Biomet on July 20, 2020 . In
addition to acquiring exclusive global distribution rights to
NeuroOne's Evo™ (Evo) patented electrode technology, the
partnership also offered the potential for NeuroOne to earn
back-end milestone payments if certain events were met within a
specified time frame.
NeuroOne received FDA clearance for its Evo cortical
technology in November 2019 .
In partnership with Mayo Clinic, Wisconsin Alumni Research
Foundation (WARF) and other prominent academic medical centers, the
Company began developing its cortical electrode technology in 2015.
The Company initially focused its efforts on the epilepsy and
intraoperative tumor monitoring markets. NeuroOne intends to
continue to develop the technology for use in therapeutic
applications for Parkinson's disease, epilepsy and pain management
due to failed back surgery procedures.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/neuroone-to-host-third-quarter-2021-earnings-call-301353737.html
SOURCE NeuroOne Medical Technologies Corporation